Objectives: Dementia-specific anxiety scales in the Norwegian language are lacking; the aim of this study was to investigate the validity and inter-rater reliability of a Norwegian version of the Rating Anxiety in Dementia (RAID-N) scale. Method: The validity of the RAID-N was tested in a sample of 101 patients with dementia from seven Norwegian nursing homes. One psychogeriatrician (n D 50) or a physician with long experience with nursing home patients (n D 51) 'blind' to the RAID-N score diagnosed anxiety according to DSM-5 criteria of generalised anxiety disorder (GAD). A receiver operating characteristic (ROC) analysis assessed the best cut-off point for the RAID-N, and the area under the curve (AUC) was calculated.
Introduction
Dementia is prevalent in later life and is a burden to patients and caregivers. The number of people in Norway with dementia as estimated in 2012 by Alzheimer Europe was approximately 77,000 (Garden & Toft, 2013) , and this number is expected to double by 2040 (Prince et al., 2013) . About 40% of patients with dementia in Norway live in institutions, mainly in nursing homes (Engedal, Braekhus, & Haugen, 2009) . Anxiety is frequently reported in patients with dementia, with prevalence rates of anxiety disorders ranging from 5% to 21% for, predominantly, generalised anxiety disorder (GAD), and from 8% to 71% for anxiety symptoms (Seignourel, Kunik, Snow, Wilson, & Stanley, 2008) . In a 2015 Norwegian study (Bendixen & Engedal, 2015) using the Geriatric Anxiety Inventory (GAI) developed by Pachana et al. (2007) , the prevalence rate of anxiety in patients with dementia admitted to the departments of geriatric psychiatry was found to be 38.8%. The variation in the prevalence of anxiety in patients with dementia may partly be explained by the different sample characteristics, diagnostic criteria applied to diagnose anxiety, and screening instruments used to detect anxiety in this group of patients. What's more, none of the previously reported studies used a dementia-specific assessment tool to detect anxiety. When anxiety co-occurs with dementia, it has often been associated with decreased functions in the activities of daily living (Teri et al., 1999) , increased dependency (Orrell & Bebbington, 1996) , an increased number of behavioural problems (Gibbons et al., 2002; Ownby, Harwood, Barker, & Duara, 2000; Teri et al., 1999) , a greater risk for nursing home placement (Gibbons et al., 2002) , and an additional burden on the patients and caregivers (Cooper, Balamurali, & Livingston, 2007) .
It is difficult to diagnose anxiety in patients with dementia. First, symptoms co-occur in dementia and anxiety. Second, it is difficult to distinguish between anxiety and depressive symptoms. Third, the influence of the source of information makes it more difficult, and finally, there is a lack of valid and adequate rating scales to identify anxiety in patients with dementia (Seignourel et al., 2008) . In clinical practice, there is a tendency to consider anxiety symptoms and anxiety disorders as part of the dementia. As a result, anxiety as a diagnosis in need of treatment often goes unnoticed in these patients.
A literature search performed in the databases Pubmed, PsycINFO, and CINAHL PLUS (January 2014) revealed that very few validated instruments for anxiety screening in patients with dementia exist, and few of them include assessment of the patients' own experience. The Worry Scale by LaBarge (1993) is a self-reporting scale designed to assess worries specifically for persons with mild dementia. The GAI is a selfreporting scale that can be used in a structured interview to assess anxiety in older people (Pachana et al., 2007) , which is, therefore, difficult to apply to patients with severe dementia.
The Rating Anxiety in Dementia (RAID) scale is meant for assessing anxiety at all stages of dementia (Shankar, Walker, Frost, & Orrell, 1999) . Furthermore, by using multiple sources of information including the person's own experience, the RAID scale is considered to be one of the most adequate instruments for assessing anxiety in patients with dementia (Seignourel et al., 2008) . Several studies of anxiety in dementia have used the RAID scale (Calleo et al., 2011; Cooke, Moyle, Shum, Harrison, & Murfield, 2010; Neville & Teri, 2011; Paukert et al., 2010) , but only a few studies have investigated its validity and inter-rater reliability (Shankar et al., 1999; Snow et al., 2012; Twelftree & Qazi, 2006) . Currently there is no dementiaspecific screening instrument for assessing anxiety translated into Norwegian. The aim of the present study was to investigate the validity and inter-rater reliability of the Norwegian version of the RAID scale as an anxiety assessment tool for patients with dementia in the Norwegian nursing homes population.
Methods

The RAID Scale
The RAID scale includes 20 items, of which 18 can be scored from 0 (absent) to 3 (severe) or U (symptoms unable to measure). Five items each assess worry (worry about physical health, cognitive performance, finances, false belief or perceptions, and worry over trifles) and somatic symptoms (palpitations, dry mouth, hyperventilating, dizziness or lightheadedness, and sweating). Some of the items evaluate sleep disturbance, irritability, and restlessness. Information about the patient's symptoms over the past two weeks is collected from the caregiver, clinical observations, medical records, and the patient himself/herself. For each item, the clinician determines a single score based on this information. There are two questions about phobias and panic attacks in the scale, but these two questions were not included in the sum score in the original version of the RAID scale: 'This was considered to be too extensive to be covered fully in the scale' (Shankar et al., 1999, p. 45) . Additionally, we wanted to validate the scale's power to detect GAD in patients with dementia, thus we found it reasonable to leave out these two items. A total score is obtained by summing up the single scores of the remaining 18 items. The minimum score is 0, and the maximum score is 54. A cut-off score of 11 provides a sensitivity of 90% and specificity of 78.5% for identifying anxiety (Shankar et al., 1999) .
Translation of the RAID scale
After obtaining permission from the original author, the RAID scale was first translated into Norwegian by a native, experienced geriatrician who is proficient in English. An optimal consensus of the translation was achieved by consulting one psychogeriatrician and one specialised nurse, both experienced in psychogeriatric medicine and proficient in Norwegian and English. A specialised and experienced nurse in psychogeriatric medicine who is a native English speaker back-translated the Norwegian version of the RAID (RAID-N) into English without previous exposure to the RAID scale. After feedback from the original author, the RAID-N scale was slightly altered to achieve conceptual equivalence between the original and Norwegian versions of the RAID scale. To check the clarity and appropriateness of the target language version, the final version of the RAID-N scale was tested by three raters by assessing eight Norwegian patients with and without dementia from a psychogeriatric department (Maneesriwongul & Dixon, 2004) . The raters found RAID-N easy to understand, thus, no further alterations were made to the scale. However, the raters' feedback and discussion were helpful in developing the guidelines for the administration of the RAID-N.
Validity study
The validity study of the RAID-N scale was carried out in accordance with the rules of evidence-based literature (Jaeschke, Guyatt, Sackett, & Evidence-Based Medicine Working Group, 1994) . The DSM-5 criteria of GAD were used as the 'gold standard' for assessing anxiety in patients with dementia. The criterion validity of the RAID-N scale was investigated by comparing the scores of the RAID-N scale with GAD diagnoses assessed by the doctors: a psychogeriatrician or a physician with long experience with nursing home patients.
The participants
Women and men 65 years and older, living in nursing homes, and fulfilling DSM-5 (American Psychiatric Association, 2013) criteria of a neurocognitive disorder of any aetiology were included in the validity study. The exclusion criteria were patients who were terminally ill and patients with schizophrenia. One hundred and nine eligible participants were assessed by an experienced psychogeriatrician (n D 56) or a physician with long experience with nursing home patients (n D 53). However, to achieve a mutual understanding of the diagnostic procedures, the two doctors discussed how to best diagnose the patients before the onset of assessments. Eight of the participants were excluded because the RAID-N assessments for five participants were more than one week old, two participants did not fulfil the DSM-5 criteria of any neurocognitive disorder, and the next of kin of one participant withdrew consent on behalf of the participant. Thus, a total of 101 participants from seven nursing homes in the southernÀeastern part of Norway were included in the validation study. Recruitment took place from September 2014 to April 2015.
Administration of the RAID-N in the validity study
Standardised guidelines for the administration of the RAID-N were developed in Norwegian before this study's onset. The guidelines were based on the original authors' article (Shankar et al., 1999) , a structured interview guide for the administration of the RAID scale (RAID-SI) by Snow et al. (2012) , and the raters' feedback after pilot testing the RAID-N. The RAID-N scale was administered by the patients' primary nurses, who were trained by the project nurse. The RAID-N scores were based on patients' symptoms over the past two weeks.
Procedure for the diagnosis of GAD
Within a week of the RAID-N scale assessment, the doctors, using a template for the symptoms of GAD according to criteria of the DSM-5, first interviewed each patient and then the patient's caregiver (usually a qualified nurse), as well as used information from the patient's medical records. The doctors were 'blind' to the scores on the RAID-N scale. Based on their clinical judgement, the doctors assessed if the patient had GAD. If yes, the degree of the anxiety's severity (mild, moderate, or severe) and whether the patient required treatment were recorded.
Procedure for the diagnosis of dementia and depression
The diagnosis of a major or mild neurocognitive disorder due to Alzheimer's disease (AD) or other subtypes of dementia was based on the DSM-5 diagnostic criteria, as was the diagnosis of major depressive disorder (MDD) and persistent depressive disorder (dysthymia). Doctors used a template with a comprehensive list of symptoms required for the above-mentioned diagnoses during the interviews.
Reliability study
An inter-rater reliability study was carried out for a subgroup of 53 participants, 50 of whom were included in the validation study. The size of 53 was considered enough to calculate Cohen's kappa statistics for each item of the RAID-N (see section Statistical analysis). Inter-rater tests were conducted by two nurses who were experienced in the dementia field. One of the nurses was the project nurse and the other was employed at one of the study sites. To obtain a mutual understanding of the RAID-N items between the raters, pilot interviews with two patients were conducted before the study. The raters independently interviewed the participants on the same day (n D 49) or the following day (n D 4), followed by the interview with the caregiver, a nurse, or nurse's aide with knowledge about the participant. The raters conducted interviews with the caregivers separately, or one rater interviewed the caregiver and the other rater asked questions for clarifications. In addition, any relevant information from the patient's medical record about the symptoms over the past two weeks was collected. Information from the caregivers and medical records was considered as more important. A patient's information was taken into account for the symptoms of autonomic hypersensitivity, and/or where the caregiver was uncertain about the information. The raters made final assessments of the RAID-N items independently.
Other measurements
In addition to the participants' demographic data, assessments were made using the Mini-Mental State ExaminationÀNorwegian Revised 2 (MMSE-NR2) (Folstein, Folstein, & McHugh, 1975; Strobel & Engedal, 2014) and the Clinical Dementia Rating Scale-Sum of Boxes (CDR-SOB) (Hughes, Berg, Danziger, Coben, & Martin, 1982; O'Bryant et al., 2008) to determine the patient's degree of cognitive impairment and stage of dementia, respectively. The minimum score on the MMSE-NR is 0 and the maximum is 30; a higher score indicates better cognitive function (Folstein et al., 1975; Strobel & Engedal, 2014) . CDR-SOB scores range from 0 to 18. Scores in the 4.5À9.0 range denote mild dementia; from 9.5 to 15.5, moderate dementia; and from 16.0 to 18, severe dementia (O'Bryant et al., 2008) .
The participants were further assessed with the Norwegian version of the Cornell Scale for Depression in Dementia (CSDD) (Alexopoulos, Abrams, Young, & Shamoian, 1988; Barca, Engedal, & Selbaek, 2010). The CSDD has 19 items assessing depressive symptoms over the past week. The total range of possible CSDD scores is from 0 to 38, where a higher score indicates more severe depression. The patients' neuropsychiatric symptoms (NPS) were assessed by the Neuropsychiatric Inventory-Questionnaire (NPI-Q) based on caregiver observations (Kaufer et al., 2000) . The scale has 12 items assessing the severity of NPS over the previous month. The total score range on the NPI-Q is from 0 to 36, and a higher score represents more severe NPS (Kaufer et al., 2000) . The measurements were administered by the patients' primary nurses.
Ethics
This study was approved by the Regional Committee for Medical and Health Research Ethics (REK) in South-Eastern Norway (ref. 2012/1958) . Written informed consent was collected from the patients (n D 43), or from the next of kin (n D 58) if the patients had reduced or no capacity to give consent.
Statistical analysis
Statistical analyses were performed by IBM SPSS Statistics, Version 21.0 (Armonk, NY, USA). The sensitivity and specificity of the RAID-N scale were assessed by the receiver operating characteristic (ROC) curve for different cut-off points on the RAID-N score and the area under the curve (AUC) was calculated. Accuracy, sensitivity, specificity, and likelihood ratios for positive (LRC) and negative (LR¡) tests at various cut-off points were calculated. Correlations between the sum scores of RAID-N, CSDD, and NPI-Q were analysed by the Pearson correlation coefficient (r). The inter-rater reliability of the RAID-N scale was assessed by intraclass correlation (ICC). Agreement between the two raters for each item of the RAID-N was examined by Cohen's kappa (k). For this purpose, we dichotomised the ratings: symptom present or not present. To do such a calculation, the number of participants should be at least 2 £ n £ n, where n is the number of cells in a 2 £ 2 table (2 £ 4 £ 4 D 32) (Cicchetti, 1976) . The internal consistency of each item and the overall scale except for phobias and panic attacks were tested by Cronbach's alpha. P values 0.05 were considered statistically significant.
Results
Demography and clinical data
The demographic characteristics of the participants are presented in Table 1 . All the participants in the study were ethnic Norwegian. Most of the participants (n D 68) had major neurocognitive disorders due toAD. The remaining participants had mild neurocognitive disorder due to AD (n D 2); vascular neurocognitive disorder (VD) (n D 18); frontotemporal neurocognitive disorder (FTD) (n D 2); or mixed neurocognitive disorders: AD and VD (n D 4), AD and FTD (n D 1), AD and neurocognitive disorder with Lewy bodies (n D 1), and unspecified neurocognitive disorder (n D 5). MMSE-NR2 scores for seven participants were not assessable due to a severe stage of dementia (n D 6) and significant impaired vision and hearing (n D 1). For the rest of the 94 participants scored by MMSE-NR2, 93 scored below 24, and the mean score (n D 94) was 14.0 (SD 5.6) ( Table 1) .
Validity study
Twenty-eight of 101 participants (27.7%) met the criteria of GAD based on the DSM-5 diagnostic criteria. Participants with a GAD diagnosis had a mean RAID-N score of 16.1 (SD 6.3), and participants without a GAD diagnosis had a mean RAID-N score of 8.8 (SD 6.5; p < 0.001). Unspecified or other anxiety disorders were found in four participants. MDD was found in 12 (11.9%) of the participants based on the DSM-5 diagnostic criteria. Eight (7.9%) of the participants with MDD had GAD, and two of the participants with MDD were diagnosed with unspecified or other anxiety disorders. Persistent depressive disorder (dysthymia) was present in three participants (3.0%), and two of them had a GAD diagnosis. Comparing different RAID-N cut-off scores, a cut-off score of 11 gave the best sensitivity but only fairly good specificity, whereas a cut-off of 12 gave the best specificity and accuracy in diagnosing GAD in patients with dementia. Results of the ROC analysis are presented in Table 2 .
To investigate whether the stage of dementia had any impact on the RAID-N scale's validity, we divided the sample into two groups based on CDR-SOB <14 and 14 (median CDR-SOB 14). An ROC analysis compared the groups to find the best cut-off score on the RAID-N scale. Sensitivity, specificity, accuracy, LRC, and LR¡ for the best cut-offs (11 and 12) are presented in Table 3 .
The total RAID-N score correlated strongly with both the total CSDD score (Pearson r D 0.65) and the total NPI-Q score (Pearson r D 0.64), both statistically significant ( p < 0.001).
Inter-rater reliability tests
The inter-rater reliability of the total RAID-N score was 0.82 at ICC coefficient (single measure). The inter-rater reliability for single items of the RAID-N questions (symptoms present or not) was analysed and is shown in Table 4 , with Cohen's kappa ranging from 0.23 (dry mouth, sinking feeling in the stomach) to 0.74 (restlessness) and a mean kappa of 0.51. A total RAID-N score of 11 and 12 resulted in similar agreement between the two raters in 42 out of 53 cases (79.2%), with Cohen's kappa at 0.58 (Table 4 ). The McNemar test indicated no systematic bias ( p D 1) between the two raters.
Internal consistency
The total Cronbach's alpha for all the RAID-N questions was 0.81. Correlation between each single item and the sum RAID-N score was above 0.25, except for question 13 where it was 0.14. Eliminating question 13 from the RAID-N score increased the Cronbach's alpha to 0.82.
Discussion
To the best of our knowledge, this is the first translation of the RAID scale investigating its psychometric properties. Patients with a GAD diagnosis had a significantly higher mean score on the RAID-N than those without GAD in this study, and the results are in line with the findings of Shankar et al. (1999) and Snow et al. (2012) . This can be explained by the fact that some items on the RAID scale such as worry, apprehension and vigilance, and motor tension are also present in the DSM-5 GAD criteria. Using the DSM-5 criteria of GAD as the 'gold standard' for diagnosing anxiety in patients with dementia, the AUC value by ROC analysis was 0.80 (SE D 0.04; 95% CI D 0.71À0.89), indicating that the RAID-N distinguishes fairly well between patients with and without GAD. Snow et al. (2012) used the Mini International Neuropsychiatric Interview (M.I.N.I.) criteria of any anxiety diagnosis, including GAD in patients with dementia, and reported a similar AUC of 0.80 (SE D 0.08; 95% CI D 0.64À0.96) on the RAID-SI. Although the participants in the study by Snow et al. (2012) had anxiety scored as 4 on the anxiety item of the Neuropsychiatry Inventory (NPI-A), the authors' findings are comparable with our study and may reflect the ability of the RAID scale to screen dementia patients with anxiety disorders regardless of the diagnostic criteria used.
Our study demonstrated that a cut-off of 11 yielded good sensitivity and accuracy for a GAD diagnosis based on the DSM-5 criteria. The specificity, however, was only fairly good using this cut-off. On the other hand, a cut-off of 12 on the RAID-N scale demonstrated a higher specificity, LRC, and diagnostic accuracy, but lower sensitivity and higher LR¡ than the cut-off of 11. A cut-off score of 11 resulted in 90% sensitivity and 78.5% specificity for identifying significant clinical anxiety in the study by Shankar and colleagues. Their study consisted of a sample of 83 elderly subjects with dementia from various settings, and diagnosis of anxiety was based on a consultant psychiatrist's rating of anxiety and the modified DSM-IV GAD criteria (Shankar et al., 1999) . A cut-off score of 10, however, demonstrated 90% sensitivity and 67% specificity in the validity study of the RAID-SI (Snow et al., 2012) , indicating different optimal cut-off values when using different diagnostic criteria for anxiety in patients with mild-to-moderate dementia. By dividing the group on the basis of the CDR-SOB, the cut-off score of 12 (CDR-SOB <14.0) on the RAID-N score gave a good sensitivity of 92.3%, the best specificity at 75.8%, and LRC 3.4 and LR¡ 0.2, indicating that the RAID-N performs better as a tool in identifying GAD in patients with mild-to-moderate dementia than in patients with severe dementia. Identifying anxiety in patients with dementia is complicated because of its overlapping symptoms with dementia and depression. The cut-off scores of 11 and 12 on the RAID-N scale represent the best diagnostic accuracy, sensitivity, and specificity with marginal differences. A cut-off of 11 that has a higher sensitivity (85.7%) than 12 would perhaps be better used in clinical practice than in research studies.
A strong correlation between the total scores on the RAID-N and the CSDD is not surprising. The coexistence of anxiety and depression is well known (Bergh & Selbaek, 2012; Bierman, Comijs, Jonker, & Beekman, 2007; Seignourel et al., 2008) ; however, only less than half of the variance (r D 0.65; r 2 D 0.42) in the RAID-N score is explained by CSDD. This strengthens the validity of RAID-N, which shows that anxiety measured by RAID-N is other than depression. The same is true for the correlation between the total RAID-N score and the total NPI-Q score (Pearson r D 0.64), supporting the cooccurrence of NPS and anxiety in patients with dementia. Our findings are consistent with the study by Neville and Teri (2011) that used the RAID scale and the Revised Memory and Behaviour Problems Checklist (RMBPC) among older people with dementia in assisted-living facilities.
The results of this study demonstrated a satisfactory internal consistency (Cronbach's alpha 0.81), close to 0.83 (Shankar et al., 1999) and 0.79 (Twelftree & Qazi, 2006) , but higher than the 0.75 as found in the study by Snow and colleagues (2012) . Unlike the study by Shankar et al. (1999) which demonstrated an overall inter-rater agreement from 82% to 100%, in our study a moderate overall inter-rater agreement (k D 0.58) could have occurred as both the raters independently interviewed the participants. A high inter-rater agreement for the item 'restlessness' in our study supports the finding of Shankar and colleagues (1999) that restlessness is perhaps an important and observable feature of anxiety in patients with dementia À and stressful to the caregivers who rated the item À whereas the anxiety symptoms 'dry mouth, sinking feeling in the stomach' might be difficult to observe and stressful only to the patients. It indicates an extra vigilance of the caregivers to identify the subjective symptoms of anxiety among patients with dementia.
Although memory and language impairments in patients with dementia hamper the expression of their anxiety, interviewing the patients revealed worries and fears that at times patients' caregivers were not apprised of (in particular, worries about family members and physical health). In our view, it is important to collect information from the patients, their caregivers, and clinical notes to get a clear picture of anxiety concerning patients with dementia.
Strengths and limitations
This study has some limitations. We have not interviewed the assessors about the relevance or comprehensiveness of the RAID-N (content validity). However, this has been done through the original version of the RAID scale (Shankar et al., 1999) . In the pilot tests with three assessors, the clarity of language was a main issue. The strength of the study is the large number of included participants solely from nursing homes, a patient group that has often been overlooked. We have followed the evidence-based rules of validation as recommended by Jaeschke et al. (1994) . All patients were assessed in the same way, and the diagnosis of anxiety was made by doctors blind to the RAID-N scores. Furthermore, the translation process for the RAID-N scale was adequate, including back-translation and monolingual testing. Hence, the RAID-N scale fulfils the criteria to be used in cross-cultural studies (Maneesriwongul & Dixon, 2004) .
In sum, the RAID-N scale has demonstrated fairly good validity and inter-rater reliability. This dementia-specific anxiety scale can be a useful tool to identify significant clinical anxiety in patients with dementia living in Norwegian nursing homes, and is thereby helpful for health professionals to initiate appropriate interventions to combat anxiety in this group of patients. More studies are needed to investigate the optimal cut-off score for the RAID-N scale in different settings, such as geriatric psychiatric departments and community dwellings.
